These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34858010)

  • 41. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
    Dong FH
    Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.
    Nagore E; Ramos P; Botella-Estrada R; Ramos-Níguez JA; Sanmartín O; Castejón P
    Acta Derm Venereol; 2001; 81(4):291-3. PubMed ID: 11720180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dermoscopy of Mycobacterium marinum Skin infection: A Challenging Diagnosis.
    Conforti C; Zalaudek I; Vichi S; Di Meo N
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):278-279. PubMed ID: 31969244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An outbreak of Mycobacterium chelonae infections in tattoos.
    Drage LA; Ecker PM; Orenstein R; Phillips PK; Edson RS
    J Am Acad Dermatol; 2010 Mar; 62(3):501-6. PubMed ID: 19733936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survey on the prevalence and utilization characteristics of gua sha in the Hong Kong community.
    Lam CT; Tse SH; Chan ST; Tam JK; Yuen JW
    Complement Ther Med; 2015 Feb; 23(1):46-54. PubMed ID: 25637152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Widespread primary cutaneous infection with Mycobacterium fortuitum.
    Rotman DA; Blauvelt A; Kerdel FA
    Int J Dermatol; 1993 Jul; 32(7):512-4. PubMed ID: 8340187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Gua Sha therapy on perimenopausal syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Ren Q; Yu X; Liao F; Chen X; Yan D; Nie H; Fang J; Yang M; Zhou X
    Complement Ther Clin Pract; 2018 May; 31():268-277. PubMed ID: 29705467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrapulmonary infections caused by a dominant strain of Mycobacterium massiliense (Mycobacterium abscessus subspecies bolletii).
    Cheng A; Liu YC; Chen ML; Hung CC; Tsai YT; Sheng WH; Liao CH; Hsueh PR; Chen YC; Chang SC
    Clin Microbiol Infect; 2013 Oct; 19(10):E473-82. PubMed ID: 23718188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of localized cutaneous infection caused by Mycobacterium scrofulaceum with clarithromycin.
    Jang HS; Jo JH; Oh CK; Kim MB; Lee JB; Chang CL; Kwon YW; Kwon KS
    Pediatr Dermatol; 2005; 22(5):476-9. PubMed ID: 16191006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical management of atraumatic
    Tiong CW; Nack T; Tai AYC; Friedman ND
    J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100132. PubMed ID: 31867443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing.
    Culton DA; Lachiewicz AM; Miller BA; Miller MB; Mackuen C; Groben P; White B; Cox GM; Stout JE
    Emerg Infect Dis; 2013 Mar; 19(3):365-70. PubMed ID: 23628077
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The first case of cutaneous infection with Mycobacterium parascrofulaceum.
    Zong W; Zhang X; Wang H; Xu XL; Wang Q; Tian W; Jin YL; Wu Q; Tang M
    Ther Clin Risk Manag; 2012; 8():353-8. PubMed ID: 22930638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycobacterium abscessus infections following injection of botulinum toxin.
    Fang RY; Sun QN
    J Cosmet Dermatol; 2020 Apr; 19(4):817-819. PubMed ID: 31402555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous Infection with Mycobacterium abscessus in a child.
    Brantley JS; Readinger AL; Morris ES
    Pediatr Dermatol; 2006; 23(2):128-31. PubMed ID: 16650219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Follow-up on an outbreak in Venezuela of soft-tissue infection due to Mycobacterium abscessus associated with Mesotherapy].
    Da Mata Jardín O; Hernández-Pérez R; Corrales H; Cardoso-Leao S; de Waard JH
    Enferm Infecc Microbiol Clin; 2010 Nov; 28(9):596-601. PubMed ID: 20106554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
    Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
    Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.